The mRNA wars are escalating with new claims from Arbutus
Arbutus and Genevant Sciences, are no strangers to the Unified Patent Court. Last year, the two companies filed two claims against Moderna at the The Hague local division as part of a global litigation campaign. However, the dispute did not last long. In March 2026, the parties reached a settlement.